Malnutrition during lactation is associated with hypoprolactinemia and failure in milk production. Adult rats whose mothers were malnourished presented higher body weight and serum triiodothyronine (T 3 ). Maternal hypoprolactinemia at the end of lactation caused higher body weight in adult life, suggesting an association between maternal prolactin (PRL) level and programming of the offspring's adult body weight. Here, we studied the consequences of the maternal PRL inhibition at the end of lactation by bromocriptine (BRO) injection, a dopaminergic agonist, upon serum TSH and thyroid hormones, thyroid iodide uptake, liver mitochondrial a-glycerophosphate dehydrogenase (mGPD), liver and pituitary de-iodinase activities (D1 and/or D2), and in vitro post-TRH TSH release in the adult offspring. Wistar lactating rats were divided into BRO -injected with 1 mg/twice a day, daily for the last 3 days of lactation, and C -control, saline-injected with the same frequency. At 180 days of age, the offspring were injected with 125 I i.p. and after 2 h, they were killed. Adult animals whose mothers were treated with BRO at the end of lactation presented lower serum TSH (K51%), T 3 (K23%), and thyroxine (K21%), lower thyroid 125 I uptake (K41%), liver mGPD (K55%), and pituitary D2 (K51%) activities, without changes in the in vitro post-TRH TSH release. We show that maternal PRL suppression at the end of lactation programs a hypometabolic state in adulthood, in part due to a thyroid hypofunction, caused by a central hypothyroidism, probably due to decreased TRH secretion. We suggest that PRL during lactation can regulate the hypothalamus-pituitary-thyroid axis and programs its function.
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Introduction
Some studies have shown that adverse situations that affect the development in critical periods of life, such as undernutrition or hormonal changes, would be able to influence the structure and physiology of organs and tissues in a permanent way (Walker & Courtin 1985 , Pracyk et al. 1992 , Dorner & Plagemann 1994 , de Moura & Passos 2005 . This biological phenomenon that establishes the relationship between these stimuli in critical periods of life, such as gestation and lactation, and future functional state is called programming (Lucas 1994 , Barker 2004 , de Moura & Passos 2005 .
Lactation is a critical period because in this phase important cognitive and neurological development occurs, which suggests that adverse environmental changes can cause physiological modifications that are able to predispose the development of some diseases in adulthood (de Moura & Passos 2005 , Miñana-Solis & Escobar 2006 .
We evidenced that adverse situations early in life, such as malnutrition , Dutra et al. 2003 , Fagundes et al. 2007 , de Moura et al. 2007 ) and hormonal (de Oliveira Cravo et al. 2002 , Teixeira et al. 2003 , Lins et al. 2005 , Toste et al. 2006a ,b, Bonomo et al. 2007 ) changes during lactation, could permanently affect the progeny. Maternal energy malnutrition during lactation programs for a higher body weight in adulthood; however, protein malnutrition programs for a lower body weight in the adult offspring (Passos et al. 2000 .
We have suggested a relationship between neonatal nutritional status and thyroid function in adult life, because we have demonstrated that maternal protein malnutrition during lactation programs for a hyperthyroidism at adulthood in rodents , Dutra et al. 2003 , Lisboa et al. 2008 . Recently, it was reported that women with low birth weight had a higher prevalence of hypothyroidism in adulthood (Kajantie et al. 2006) . In addition, according to Radetti et al. (2006) , prematures, independent of their birth weight or length, presented a higher prevalence of disturbance on the hypothalamus-pituitary-thyroid axis later in life.
Maternal malnutrition during lactation is associated with a failure in milk production (Passos et al. 2000) in rats, caused by hypoprolactinemia (Lisboa et al. 2006) . The bromocriptine (BRO) administration to lactating dams at the end of lactation caused milk production inhibition and neonatal malnutrition, evidenced by the lower body weight of their pups at weaning and important changes in the leptin transfer through the milk and pups' leptinemia (Bonomo et al. 2005 ) that reproduces the leptinemia of the offspring from malnourished dams . We also detected that, in adult life, offspring from BRO-treated mothers developed obesity without hyperphagia, suggesting a hypometabolic state, characterized by higher body weight, higher central and total body fat mass, hyperleptinemia and central resistance to the anorectic effect of leptin (Bonomo et al. 2007) . Also, leptin administration during lactation to the mothers or to the pups (Teixeira et al. 2003 , Toste et al. 2006a programs for higher serum tri-iodothyronine (T 3 ).
So, the present study was designed to evaluate the later repercussion of maternal hypoprolactinemia upon the programming of the thyroid function in the adult offspring.
Materials and Methods
Three-month-old Wistar rats were maintained in a room under a darkness-light cycle (0700-1900 h) and controlled temperature (25G1 8C). Virgin female rats were caged with one male rat at a proportion of 2:1. After mating, each female was placed in an individual cage with water and food made available ad libitum until parturition. The use of the animals was according to the Animal Care and Use Committee of the Biology Institute of the State University of Rio de Janeiro (CEA/186/2007), which based their analysis on the principles described in the Guide for the Care and Use of Laboratory Animals (Bayne 1996) .
Experimental model of maternal hypoprolactinemia during lactation
After birth, excess pups were removed, so that only six male pups were kept per dam, because it has been shown that this procedure maximizes lactation performance (Fischbeck & Rasmussen 1987) .
Lactating rats were separated into the following groups: BRO -treated with 1 mg bromo-a-ergocriptine s.c. (BRONovartis, São Paulo, Brazil), twice a day, for 3 days at the end of lactation, and C -control group, which received saline for the same time. We used six lactating rats per group and two pups of each dam were randomly separated (nZ12 pups).
On day 21 of lactation, dams' serum prolactin (PRL) levels were measured by specific RIA using reagents supplied by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD, NIH, Bethesda, MD, USA). Data are reported in ng/ml from the reference preparation, RP-3. Samples were analyzed in a single assay and the intra-assay coefficient was 8%. In addition, we performed an estimate of milk production as described previously (Passos et al. 2000 , Bonomo et al. 2005 .
Maternal food intake was measured. We also followed the body weight of mothers and pups during lactation.
After weaning, body weight and food intake were monitored every 4 days until 180 days. At 180 days, in order to determine the thyroid's 2 h radioiodine uptake, the offspring received a single i.p. injection containing 2 . 22!10 4 Bq of 125 I (CNEN, Rio de Janeiro, Brazil). After 2 h, animals were killed by decapitation to collect blood, thyroid, pituitary, and liver.
Thyrotropin (TSH), T 3 , and T 4 serum concentrations TSH was measured by specific RIA, using a kit for rat TSH supplied by the NIDDKD (NIH) and data were expressed in terms of the reference preparation provided (RP-3). The intra-assay variation coefficient was 7 . 1%, with 0 . 09 ng/ml as the lower limit of detection.
Total serum T 3 (TT 3 ) and thyroxine (TT 4 ) were determined by RIA, using commercial kits (ICN pharmaceuticals, Inc., Costa Mesa, CA, USA), in which we used control standard curves diluted in iodothyronine-free rat serum (charcoal treated). The intra-assay variation coefficient for T 4 was 5 . 7%, with 2 mg/dl as the lower limit of detection, and for T 3 the values were 5 . 6% and 25 ng/dl respectively.
Mitochondrial GPD activity
The liver a-glycerol-3-phosphate dehydrogenase activity (GPD) was measured in the mitochondrial fraction using phenazine methosulfate (PMS) as an electron transporter between the reduced enzyme and iodonitrotetrazolium chloride violet (INT) (Bernal et al. 1978 , Oliveira et al. 2007 ).
The assay was performed in the presence of 0 . 1 M DL-aglycerophosphate diluted in potassium cyanide (KCN)/ potassium phosphate buffer (KPB) and a solution of 7 . 9 mM INT-0 . 12 mM PMS. Samples were analyzed at 500 nm and the values were expressed as absorbance (O.D)/mg of mitochondrial protein. Protein was measured using the method described by Bradford (1976) .
Iodothyronine de-iodinase activity
Type 1 (D1) and 2 (D2) de-iodinase activities were measured based on methods described previously (Dutra et al. 2003 , Lisboa et al. 2003a ) by the release of 125 I from 125 I-reverse T 3 in the liver microsomes and the pituitary total homogenate. Assays were performed in phosphate buffer containing 1 mM EDTA (pH 6 . 9). D1 assay was performed in the presence of rT 3 (1 . 5 mM for the liver and 2 nM for the pituitary), dithiothreitol (DTT) (10 mM), and T 4 (100 nM, only for pituitary D2 inhibition). D2 assay was performed with 2 nM rT 3 , 10 mM DTT, and 1 mM 6-n-propyl-2-thiouracil (PTU) (to inhibit pituitary D1). Equal aliquots of 125 I-rT 3 (1 . 07 mCi/mg -New England Nuclear-Dupont, Boston, MA, USA), purified by paper electrophoresis were placed to each assay tube. Reaction was started by sample addition with the following amount of protein:
I T BONOMO and others . Prolactin programs thyroid function 70-150 mg for the pituitaries and 12-20 mg for the liver. A blank tube was run in parallel with each assay, containing 50 ml of the substrate solution and 50 ml buffer, which had its values subtracted from enzyme samples. Reactions were performed on a shaking-bath at 37 8C, and stopped after 30 (liver D1) or 60 (pituitary D1 and D2) minutes by the addition of a mixture of 8% BSA and 10 mM PTU, followed by 20% cold trichloroacetic acid. Samples were centrifuged (1500 g, 4 8C, 5 min) and 200 ml of the supernatants were applied to Dowex 50 W-X2 columns (100-200 mesh hydrogen form Bio-Rad). Free 125 I, eluted from the column with 10% acetic acid, was measured in a g-counter.
De-iodination percentual in the presence of the enzyme was around 10-20%. The amount of free 125 I in blank was generally less than 1-2% of the total radioactivity in the reaction mixture. The specific enzyme activity was expressed by nanomoles or fentomoles of rT 3 de-iodinated/h mg of protein. Protein was measured by the method described by Bradford (1976) .
In vitro TRH-stimulated TSH release
Pituitaries of C and BRO groups were quickly dissected out. The anterior pituitary was separated from the posterior pituitary and transected with a longitudinal midline cut. Each anterior hemipituitary was transferred to a tube containing 1 ml KrebsRinger-bicarbonate medium (pH 7 . 4) and incubated at 37 8C in an atmosphere of 95% O 2 -5% CO 2 in a Dubnoff metabolic shaker (50 cycles/min). After preincubation (20 min), the medium was removed and hemipituitaries were resuspended in 1 ml fresh medium. After 1-h incubation, an aliquot was removed for measurement of basal TSH, and thyrotropinreleasing hormone (TRH) (Sigma) was added at final concentration of 50 nM. Then, glands were incubated for 30 min to determine the TSH release in response to TRH. Each hemipituitary was homogenized in phosphate buffer saline (pH 7 . 6) for measurement of intra-pituitary TSH content (Rettori et al. 1992 , Moreira et al. 1997 , Moura et al. 2001 , Veiga et al. 2004 , Lisboa et al. 2008 . Protein content was measured by the Bradford method (Bradford 1976) . The medium and pituitary TSH levels were measured by specific RIA.
Statistical analysis
Data are represented as meanGS.E.M. Body weight and food intake evolutions were analyzed by two-way ANOVA followed by Newman-Keuls multiple comparison tests. The statistical significance of TSH and thyroid iodide uptake were determined by the Mann-Whitney test and the other experimental observations by the Student's unpaired t-test, with significance level set at P!0 . 05.
Results
As expected, BRO-treated mothers showed lower serum PRL at the end of lactation (day 21: K96%, P!0 . 01), which caused a significant failure in milk production (Table 1) . However, milk PRL of BRO dams and serum PRL of the BRO pups were not altered (Table 1) . At weaning (Table 2) , BRO dams showed lower food ingestion (K25%) and both mothers and pups presented lower body weight (K10 and K7% respectively, P!0 . 01). Table 3 shows that 180-day-old animals' mothers that received BRO at the end of lactation presented higher total body weight (10%, P!0 . 05) without changes in the food intake (g/day), corroborating our previous study (Bonomo et al. 2007) .
These animals presented lower serum TSH (K51%, P!0 . 001, Fig. 1 ), lower thyroid 125 I uptake (K41%, P!0 . 05, Fig. 2 ), and lower total serum thyroid hormone levels (T 3 : K23%; P!0 . 05, Fig. 3A and T 4 : K21%; P!0 . 05, Fig. 3B ). Liver mitochondrial GPD (mGPD) activity, which is a T 3 -dependent enzyme, was also lower (K55%, P!0 . 05, Fig. 4 ).
Pituitary and liver D1 activity was not affected (Fig. 5a and b respectively) in adult animals whose mothers were BRO treated; however, pituitary D2 activity was lower in BRO group (K51%, P!0 . 05, Fig. 5c ). The in vitro TSH release after TRH stimulation was similar in both groups (Fig. 6) . 
Discussion
We showed that the maternal blockage of serum PRL concentration with BRO, a specific dopamine D2 agonist, caused a calorie restriction to the offspring, since milk production was suppressed. The lower body weight in the BRO-treated mothers reinforces the concept that PRL may play a stimulatory effect on body weight gain during lactation (Fleming 1976) . Thus, the BRO treatment was useful not only to address the importance of PRL, but also serves as an experimental model for energy restriction, since both mothers and pups showed a lower body weight at weaning. Present data from animals whose mothers were BRO treated at the end of lactation reinforces our previous study of higher body weight, increase in total body fat mass, and normal food intake (Bonomo et al. 2007), suggesting a hypometabolic state. It is well documented that thyroid hormones exert important role in thermogenesis and basal metabolic rate (Silva 2006) , so this hypometabolic state can be related to the lower serum thyroid hormone levels found in these programmed animals.
The lower serum thyroid hormone concentrations presented by adult BRO animals can be explained by the lower TSH concentration. As it was already demonstrated that leptin stimulates TRH and TSH production and secretion (Legradi et al. 1997 , Seoane et al. 2000 , Ortiga-Carvalho et al. 2002 , it is possible that the decrease in serum TSH could be secondary to a hypothalamic leptin resistance. The adult offspring whose mothers were BRO treated at the end of lactation presented a central leptin resistance (Bonomo et al. 2007) , characterized by a lack of leptin's anorexigenic effect. The lower thyroid iodide uptake is another thyroid dysfunction caused by the lower TSH level that can impair thyroid hormone biosynthesis.
The lower liver mGPD activity, a specific tissue marker of thyroid function (Coleoni et al. 1983 , Brown et al. 2002 , can be explained by the hypothyroidism detected in the adult BRO group, since mGPD is a T 3 -dependent enzyme. This enzyme is responsible for transforming glycerol in dihydroxyacetone phosphate and for producing reduced equivalents to the respiratory chain, during lipolysis, and could also contribute to thermogenesis (Lardy et al. 1995 , Koza et al. 1996 , Bobyleva et al. 2000 , dos Santos et al. 2003 . So, we can suggest that the lower liver mGPD activity could be related to the hypometabolism observed in these animals (Bonomo et al. 2007) .
Liver D1 activity, another T 3 -dependent enzyme, that is generally lower in hypothyroidism (Bianco & Kim 2006) , showed no change in BRO animals. We suggest that the unchanged D1 activity was due, at least in part, to the hyperleptinemia of these animals (Bonomo et al. 2007) , since it was already described that leptin increases liver D1 activity (Cusin et al. 2000 , Lisboa et al. 2003b . Therefore, the hyperleptinemia could help in maintaining this enzyme activity, despite the lower thyroid hormone levels.
The in vitro TSH release after TRH stimulation was increased in a similar way in both groups (C and BRO), suggesting that the lower serum TSH is not caused by a pituitary failure in TSH synthesis and/or secretion. Then, it is possible that neonatal hypoprolactinemia programs for a hypothalamic failure in the TRH production and/or release in adult offspring. Paradoxically, pituitary D2 was lower when a higher activity was expected, since the animals were hypothyroid (Bianco & Kim 2006) . The lower pituitary D2 activity in adult BRO animals reinforces the hypothesis that the hypothyroidism observed in this group is associated with a possible TRH-related defect, since it was already shown that pituitary D2 is stimulated by TRH (Kim et al. 1998) .
In the present study, we suggest some mechanisms induced by the maternal PRL blockage as responsible for the programming of the hypothalamus-pituitary-thyroid axis in adulthood. In general terms, programming occurs through epigenetic mechanisms, such as DNA methylation or histone acetylation, induced by neonatal stressful events (nutritional, hormonal, or environmental) and may lead to an increased risk of metabolic diseases in the adult offspring (de Moura & Passos 2005 ), e.g. thyroid dysfunctions , Dutra et al. 2003 . One of the possible imprinting factors that could act as triggering the epigenetic phenomena is the hyperleptinemia, since we already showed a higher leptin transfer and pup's hyperleptinemia at weaning in this same In vitro TSH release before and after TRH stimulation from pituitaries of 180-day-old rats whose dams were BRO treated or saline treated during 3 days of lactation. Values are given as the meanGS.E.M.; * model of PRL inhibition (Bonomo et al. 2005) . Also, maternal malnutrition is associated with pup's hyperleptinemia at the end of lactation and programs for higher serum T 3 (Teixeira et al. 2003 , Toste et al. 2006a . It is unlikely that BRO transferred through the milk could affect directly the PRL of the pups, since we have not detected any change in pups' PRL. Thus, these explanations may help to understand the mechanism by which the maternal hypoprolactinemia during lactation permanently change the thyroid function. Perhaps this change can turn undernourished children more susceptible to thyroid disorders in adult life , Dutra et al. 2003 , Lisboa et al. 2008 , although it deserves epidemiological and prospective studies.
So, for the first time, we demonstrated that maternal PRL inhibition by the treatment with BRO for a short period at the end of lactation programs for hypothyroidism in the adult offspring, which may originate from a central dysfunction, probably caused by lower TRH release. Taken together, our data provide new evidence that PRL changes during lactation play a crucial role in the regulation of body adiposity and thyroid function. 
